AMCP Trump Administration Actions Tracker
AMCP tracks presidential actions affecting the practice of managed care pharmacy. This tracker includes executive orders (EOs), memorandums, proclamations, and nominations released by the Trump administration on or after Jan. 20, 2025.
Check back every Monday for weekly updates!
Jump to: Health Care | Federal Workforce/General Government | Trade Tariffs | Nominees/Appointees | HHS Leadership
Health Care
| Action | Number/Name | Issue Date | Effect | Timeframe | Link | Litigation |
|---|---|---|---|---|---|---|
| Memorandum | Preventing Illegal Aliens from Obtaining Social Security Act Benefits | 4/15/25 | Directs the administration to issue guidance restricting ‘ineligible aliens’ ability to receive funds from Social Security Act programs, including Medicare, Medicaid, Supplemental Security Income, SNAP, and TANF. Expands the agencies fraud protector program to 50 US Attorneys offices and establishes a Medicare and Medicaid fraud program in 15 USA offices. | Effective immediately. Within 60 days of the order, the Social Security Commissioner must review whether SSA should continue civil monetary penalties. | ||
| Executive Action | 14273 - Lowering Drug Prices by Once Again Putting Americans First | 4/15/25 | Aimed at reducing prescription drug costs for American patients and taxpayers. It includes 13 directives for agencies across various programs, such as Medicare and Medicaid, requiring them to produce findings or propose regulations by specific deadlines. | Federal Register | ||
| Executive Action | 14239 - Achieving Efficiency Through State and Local Preparedness | 3/19/25 | This Executive Order mandates the creation of a National Resilience Strategy within 90 days, along with an extensive assessment and possible updates, eliminations, and substitutions of existing policies concerning critical infrastructure, supply chains, and national emergency readiness. | N/A | Federal Register | |
| Executive Action | 14236 - Additional Rescissions of Harmful Executive Orders and Actions | 3/14/25 | The current administration has overturned 18 executive orders and actions from former President Biden, including Executive Order 13994, which is titled "Ensuring a Data-Driven Response to COVID-19 and Future High-Consequence Public Health Threats." This order aimed to improve the federal government's data collection and reporting regarding COVID-19 and other significant public health issues, ensuring that important equity indicators are taken into account. | N/A | ||
Executive Order
|
14221 – Making America Healthy Again by Empowering Patients With Clear, Accurate, and Actionable Healthcare Pricing Information
| 2/25/25 | HHS, DOL, and Treasury must require disclosure of actual prices for health care items and services furnished, requires agencies to issue guidance on information standardization and enforcement policies for transparency rules | Within 90 days of the order |
| |
| Executive Order | 14216 - Expanding Access to In Vitro Fertilization | 2/18/25 | Instructs the Assistant to the President for Domestic Policy to develop a list of policy recommendations on protecting access to IVF treatments, as well as opportunities to reduce OOP and health plan costs. | Recommendations must be submitted within 90 days of the date of this order. |
| N/A |
| Executive Order | 14214 -Keeping Education Accessible and ending COVID-19 Vaccine Mandates in Schools | 2/15/25 | Opposes the use of federal funding for schools (K-12 and higher education) or agencies that require COVID-19 vaccination. Also directs Dept. of Edu. to issue guidance to schools on their legal obligations with respect to COVID-19 vaccine mandates. | Directs the Secretary of Education to provide a plan to end COVID-19 vaccine mandates in schools within 90 days of the order. | N/A | |
| Executive Order | 14212 - Establishing the President’s Make America Healthy Again Commission | 2/13/25 | Directs federal health departments and agencies to combat the causes of chronic disease, including obesity, diabetes, and mental health disorders. Also establishes a Make America Healthy Again Commission, chaired by the HHS Secretary, which is tasked with studying the cause of and providing policy recommendations to alleviate childhood chronic disease. | Within 100 days of the enactment of this order, the Commission must submit a Make our Children Healthy Again Assessment. Within 180 days, the Commission must submit a Make Our Children Healthy Again Strategy report. | N/A | |
| Executive Order | 14187 – Protecting Children from Chemical and Surgical Mutilation | 1/28/25 | Seeks to prohibit or limit federal support for gender affirming care for transgender children. Directs HHS to provide new guidance and resources on care for children experiencing gender dysphoria and rescind prior guidance on gender affirming care for children. Excludes pediatric transgender surgeries from TRICARE coverage and Federal Employee Health Benefits coverage. Directs DOJ to prioritize enforcement of protections against pediatric genital mutilation, and work with Congress to develop a private right of action for children and parents of children who have transitioned. Also expands the definition of “child” to include those under 19 years of age. | N/A | Federal Register | Injunction filed 2/4/25 U.S. District Judge Brendan A. Hurson granted temporary restraining order on 2/13/25. |
| Executive Order | 14182 – Enforcing the Hyde Amendment | 1/24/25 | Ends the use of federal dollars to promote or fund abortion, revokes two EOs on reproductive health care, 14076 and 14079. Passed in 1976, the Hyde amendment restricts federal funding for elective abortions. | N/A | ||
| Memorandum | Memorandum for the Secretary of State, the Secretary of Defense, the Secretary of Health and Human Services, the Administrator of the United States for International Development | 1/24/25 | Directs HHS, the Department of State, and USAID to reinstate the Mexico City Policy. The Mexico City Policy blocks foreign non-governmental organizations who provide abortion counseling from receiving federal funding. | N/A | White House | N/A |
| Executive Order | 14155 - Withdrawing the United States from the World Health Organization | 1/20/25 | Withdraws the U.S. from the WHO, requires NSC to establish protocols to safeguard public health, rescinds 2024 Global Health Security Strategy and Biden EO 13987 on COVID-19 mobilization | N/A | Federal Register | N/A |
| Memorandum | Delivering Price Relief for American Families and Defeating the Cost of Living Crisis | 1/20/25 | Directs all federal agencies to improve the affordability of necessary goods and services, includes action to: “eliminate unnecessary administrative expenses and rent-seeking practices that drive up healthcare costs.” | N/A | White House Fact Sheet | N/A |
| Executive Order | 14148 – Initial Rescissions of Harmful Executive Orders and Actions | 1/20/25 | Revokes dozens of executive actions from the Biden Administration, including several health care-related actions on COVID-19 pandemic preparedness, health equity, and drug pricing. | N/A | White House AMCP Policy Brief | N/A |
Jump to: Health Care | Federal Workforce/General Government | Trade Tariffs | Nominees/Appointees | HHS Leadership
Federal Workforce/General Government
| Action | Number/Name | Issue Date | Effect | Timeframe | Link | Litigation | |
|---|---|---|---|---|---|---|---|
| Executive Order | # - Restoring Equality of Opportunity and Meritocracy | 4/23/2025 | Directs the federal government to eliminate the use of disparate-impact liability in all contexts, revoking previous EOs that ensure federal programs are not “perpetuating the repercussions of past discrimination.” Also directs agencies to deprioritize enforcing regulations and laws that include disparate-impact liability. | Within 30 days, the AG must compile a report of all existing regulatory releases that impose disparate-impact liability. Within 45 days, the AG must identify all pending investigations and suits that rely on disparate impact liability. | |||
| Executive Order | # - Extension of Hiring Freeze | 4/17/25 | Extends the ongoing federal civilian employee hiring freeze through July 15, 2025. Applies to all executive departments and agencies. | Effective immediately | White House | ||
| Executive Order | 14271 - Ensuring Commercial, Cost-Effective Solutions in Federal Contracts | 4/16/25 | Federal agencies must prioritize purchasing commercially available products and services over custom solutions, per the Federal Acquisition Streamlining Act. Agencies are also required to review pending non-commercial contracts and submit justification waivers with market research and price analysis to the Office of Management | Within 60 days of this order | Federal Register | ||
| Executive Order | 14275 - Restoring Common Sense to Federal Procurement | 4/15/25 | Instructs federal agencies to update the Federal Acquisition Regulation (FAR) to include only provisions required by law or necessary for simplicity, efficacy, or the protection of economic and national security interests. | Within 15 days of this order | Federal Register | ||
| Executive Order | 14274 - Restoring Common Sense to Federal Office Space Management | 4/15/25 | Revokes previous executive orders from Presidents Carter EO 12072 and Clinton EO 13006, which focused on locating federal facilities in central business areas, enabling agencies to opt for cost-effective sites. | Federal Register | |||
| Memorandum | Directing the Repeal of Unlawful Regulations | 4/15/25 | Instructs agencies to target and begin plans to repeal unlawful or potentially unlawful regulations, relative to 10 specific Supreme Court cases. | Agencies must effectuate the repeal of unlawful rules within following the end of the 60-day review period mandated by EO 14219. Within 30 days of this date, agencies must submit a 1-page summary of each regulation repealed. | Fact Sheet | ||
| Executive Order | 14251 - Exclusions From Federal Labor-Management Relations Programs | 3/27/25 | Certain federal agencies are excluded from collective bargaining rights under the Federal Service Labor-Management Relations Statute due to national security reasons. Within HHS, the affected agencies include the Office of the Secretary, FDA, CDC, OGC, ASPR, the Office of Refugee Resettlement, and NIH's NIAID. | Federal Register | |||
| Executive Order | 14238 - Continuing the Reduction of the Federal Bureaucracy | 03/14/25 | Instructs the removal of non-mandatory elements and operations from seven federal agencies, such as the Federal Mediation and Conciliation Service and the United States Interagency Council on Homelessness. | Within seven days of this order, each government entity's head must submit a report to the Director of the Office of Management and Budget confirming compliance and identifying any legally required components or functions, along with their extent. | Federal Register | ||
Executive Order
| 14222 – Implementing the President’s “Department of Government Efficiency” Cost Efficiency Initiative | 2/26/25 | Orders agencies to record, review and pause unnecessary payments, review, terminate, and or modify all covered contracts and grants, freeze agency credit cards for 30 days, and review federal building leases | Review and terminate contracts within 30 days of the order, submit report on unneeded government property within 60 days | Federal Register | ||
| Executive Order | Commencing The Reduction of the Federal Bureaucracy | 2/19/25 | Proposal to abolish a specific group of government agencies as a way to decrease the federal government's size; it mandates that the leaders of those agencies verify adherence within a two-week timeframe. | Within 14 days of this order | White House | ||
| Executive Order | # - Ensuring Accountability for All Agencies | 2/18/25 | Aims to increase administrative oversight of independent federal agencies. Directs Director of the Office of Management and Budget (OMB) to establish management objectives and submit reports to the President on agency performance. OMB is directed to review regulatory actions to ensure they remain consistent with the administration’s priorities, and OMB may adjust apportionment for independent agencies inconsistent with the President’s priorities. Also clarifies the President and Attorney General’s power to provide “authoritative interpretations” of law. | Within 60 days of the date of this order, or the completion of implementation guidance | Litigation expected | ||
| Memorandum | Memorandum for the Heads of Executive Departments and Agencies on Advancing United States Interests When Funding Nongovernmental Organizations | 2/6/25 | Instructs federal agencies to review all funding that agencies provide to Nongovernmental Organizations (NGOs). Agency heads are instructed to align funding decisions with the goals and priorities of the Trump administration. | N/A | White House | N/A | |
| Executive Order | 14192 – Unleashing Prosperity Through Deregulation | 1/31/25 | For FY 2025, executive departments or agencies must identify 10 existing regulations to be repealed, for every new regulation promulgated. The costs of newly elected regulation shall be offset by the elimination of existing costs of the 10 repealed regulations. | Effective for FY 2025 (Oct. 1, 2024 – Sept. 30, 2025) | Federal Register Fact Sheet | ||
| Memorandum | Memorandum for Heads of Executive Departments and Agencies on Temporary Pause of Agency Grant, Loan, and Other Financial Assistance Programs | 1/27/25 | Established a temporary pause on all federal financial assistance programs | Memo withdrawn | Office of Management and Budget | Injunction filed on 2/3/25, U.S. District Judge Loren L. AliKhan filed a temporary restraining order | |
| Memorandum | Regulatory Freeze Pending Review | 1/20/25 | Requires all executive departments and agencies to withhold rulemaking prior to a review by a Trump appointed official, agencies must withdraw rules that have not been published by the Federal Register, agencies must consider postponing rules that have not been published/taken effect for 60 days | 60 days, starting at 12:00pm ET on 1/20/25 | White House |
Jump to: Health Care | Federal Workforce/General Government | Trade Tariffs | Nominees/Appointees | HHS Leadership
Trade Tariffs
| Action | Number/Name | Issue Date | Effect | Timeframe | Link | Litigation |
|---|---|---|---|---|---|---|
| Executive Order | 14272 - ENSURING NATIONAL SECURITY AND ECONOMIC RESILIENCE THROUGH SECTION 232 ACTIONS ON PROCESSED CRITICAL MINERALS AND DERIVATIVE PRODUCTS | 4/15/25 | Orders the Secretary of Commerce to start a Section 232 investigation into processed critical minerals and their derivatives | Within 90 days: Commerce will submit a draft report on the investigation for review. Within 15 days: agencies will provide comments on the draft. Within 180 days: the final report and recommendations will be sent to the president. | ||
| Executive Order | 14266 - Modifying Reciprocal Tariff Rates To Reflect Trading Partner Retaliation and Alignment | 4/9/25 | Imposes a 90-day suspension on all “reciprocal” tariffs, except for China, as stated in President Trump's Executive Order 14257; raises tariffs on Chinese imports from 84% to 125% and increases tariffs on low-value Chinese imports from 90% to 120%. | Effective 4/10/25 | Federal Register | |
| Executive Order | 14259 - Amendment to Reciprocal Tariffs and Updated Duties as Applied to Low-Value Imports From the People's Republic of China | 4/8/25 | Tariffs on Chinese imports will rise from 34% to 84%, starting on 4/9/2025, while tariffs on low-value Chinese imports will increase from 30% to 90%. | Effective 5/2/2025 | Federal Register | |
| Executive Order | 14257 - Regulating Imports With a Reciprocal Tariff To Rectify Trade Practices That Contribute to Large and Persistent Annual United States Goods Trade Deficits | 4/2/25 | President Trump announced a 10 percent baseline tariff on all imported goods starting April 5, 2025, along with “reciprocal” tariffs on select countries, at about half the rate of tariffs faced by U.S. goods. Pharmaceuticals are exempt from both tariffs. | Effective 4/9/2025 | Federal Register | |
| Executive Order | 14256 - Further Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China as Applied to Low-Value Imports | 4/2/25 | President Trump stated that the Secretary of Commerce has confirmed systems are in place to reinstate duties on all imports from China, including low-cost packages. | Effective 5/2/25 | Federal Register | |
| Executive Order | 14245 - Imposing Tariffs on Countries Importing Venezuelan Oil | 3/24/25 | A 25 percent tariff will be applied to all goods from countries importing Venezuelan oil, in addition to any existing tariffs. | Effective 4/2/25 | ||
| Executive Order | Amendment to Duties to Address the Flow of Illicit Drugs Across Our Southern Border | 3/6/25 | Updates prior Executive Orders on tariffs for Mexico: a 25 percent tariff on goods not meeting USMCA rules of origin, excluding those qualifying for USMCA preferences; a 10 percent tariff on potash outside of USMCA coverage. | Effective 3/7/25 | ||
| Executive Order | Amendment to Duties to Address the Flow of Illicit Drugs Across Our Northern Border | 3/6/25 | Revises previous executive orders on tariffs with the following changes: a 25 percent tariff on goods not meeting USMCA rules of origin, a 10 percent tariff on non-USMCA energy goods from Canada, and a 10 percent tariff on non-USMCA potash. | Effective 3/7/25 | ||
| Executive Order | Further Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People’s Republic of China | 3/3/25 | Revises the Executive Order regarding the implementation of tariffs to tackle the synthetic opioid supply chain in the People's Republic of China by raising the tariff from 10 percent to 20 percent. | |||
| Executive Order | 14226 Amendment to Duties To Address the Flow of Illicit Drugs Across Our Northern Border | 3/2/25 | Amends prior Canadian tariffs by exempting goods covered under USMCA. Reduces tariffs on energy and potash imports to 10% | Effective immediately | ||
| Executive Order | 14227 Amendment to Duties To Address the Situation at Our Southern Border | 2/25/25 | Amends prior tariffs on Mexico by exempting goods covered under USMCA, reduces tariffs on potash imports to 10% | Effective immediately | ||
| Executive Order | 14226 Amendment to Duties To Address the Flow of Illicit Drugs Across Our Northern Border | 3/2/25 | Amends prior Canadian tariffs by exempting goods covered under USMCA. Reduces tariffs on energy and potash imports to 10% | Effective immediately | ||
| Executive Order | EO 14195 - Imposing Duties to Address the Synthetic Opioid Supply Chain in the People’s Republic of China | 2/1/25 | Imposes a 10 percent tariff on Chinese goods starting February 4; revokes de minimis for these products; includes a clause for escalation if there is retaliation; states tariffs will be lifted once China addresses the opioid crisis. | N/A | Federal Register | |
| Executive Order | EO 14194 - Imposing Duties to Address the Situation at Our Southern Border | 2/1/25 | Imposes a 25% tariff on Mexican goods starting February 4; revokes de minimis for these products; includes a clause for escalation if there is retaliation; states tariffs will be lifted once Mexico resolves the "illegal migration and drug crisis." Paused on 2/3/25 until 3/4/25. | Paused until 3/4/25 | Federal Register White House | |
| Executive Order | EO 14193 - Imposing Duties to Address the Flow of Illicit Drugs Across Our Northern Border | 2/1/25 | Imposes a 25% tariff on Canadian goods starting February 4; revokes de minimis for these products; includes a clause for escalation if there is retaliation; states tariffs will be lifted once Canada resolves the "public health crisis" (illicit drugs). Paused on 2/3/25 until 3/4/25. | Federal Register White House |
Jump to: Health Care | Federal Workforce/General Government | Trade Tariffs | Nominees/Appointees | HHS Leadership
Nominees/Appointees
White House Positions | |
|---|---|
| Chief of Staff | Susie Wiles |
| Deputy Chief of Staff | Dan Scavino |
| Deputy Chief of Staff for Policy | Stephen Miller |
| Deputy Chief of Staff for Legislative, Political, and Public Affairs | James Blair |
| Deputy Chief of Staff for Communications and Personnel | Taylor Budowich |
| White House Counsel | William McGinley |
| Office of Management & Budget Director | Russell Vought (Director)* Don Dempsey (Health Program Associate Director) |
| Domestic Policy Council (DPC) | Vince Haley (Director) Theo Merkel (Special Assistant to the President - Health Care) |
| National Economic Council | Kevin Hassett (Director) Joel Zinberg (Health Care) |
| President's Council of Advisors on Science and Technology | Lynne Parker (Executive Director) David Sacks (Special Advisor for AI and Crypto) |
| White House Office of Science and Technology Policy Director* | Michael Kratsios |
*Position requires Senate confirmation | |
Jump to: Health Care | Federal Workforce/General Government | Trade Tariffs | Nominees/Appointees | HHS Leadership
Department of Health & Human Services and Sub-Agency Leadership
| Secretary of Health and Human Services | Robert F. Kennedy |
| Deputy Secretary of Health and Human Services | Vacant, nomination pending for James O'Neil |
| Chief of Staff | Heather Flick |
| Deputy Chief of Staff | Stefanie Spear (Principal Deputy, external focus), Scott Rowell (Operations), Hannah Anderson (Policy) Counselors: TBA |
| Administrator of the Centers for Medicare and Medicaid Services | Dr. Mehmet Oz |
| U.S. Surgeon General | Vacant, nomination pending for Janette Nesheiwat |
| Director of the National Institutes of Health | Vacant, nomination pending for Jayanta Bhattacharya Dr. Matthew J. Memoli (Acting) |
| Commissioner of Food and Drugs | Vacant, nomination pending for Martin Makary Dr. Sara Brenner (Acting) |
| Director of the Centers for Disease Control and Prevention | Vacant, Nomination pending for David Weldon Dr. Susan Monarez (Acting) |
| Administrator of the Health Resources and Services Administration | Thomas J. Engels |
| Assistant Secretary for Preparedness and Response | Vacant, nomination pending for Houston Park |
| Director of the Advanced Research Projects Agency for Health | Vacant |
| Deputy Administrator for the Center for Medicare | Ing-Jye Cheng (Acting) |
| Director of the Center for Medicaid & CHIP Services | Drew Snyder |
| Deputy Administrator for the Center for Medicare and Medicaid Innovation | Abe Sutton |
